BSX:NYSEBoston Scientific Corporation analysis
Data as of Oct 15, 2026 - not real-time
- Latest price
- $43.91
- Risk: medium
- 6/10Medium risk
Summary
Boston Scientific Corporation trades at $43.91, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. The last 30 days have lost 9.2%. Momentum indicators put RSI at 49.8 (neutral) with MACD reading bullish. Recent trading has carved out support near $41.39 and resistance around $45.74.
On valuation the read is undervalued — earnings multiple of 17.9 versus a 31.8 sector average, below the peer group. Sell-side targets cluster 34.9% above the current quote. Revenue is growing at 7.5% on a 17.5% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 33.4%, a beta of 0.17 and a maximum drawdown of 60.4%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 6 out of 10.
On valuation the read is undervalued — earnings multiple of 17.9 versus a 31.8 sector average, below the peer group. Sell-side targets cluster 34.9% above the current quote. Revenue is growing at 7.5% on a 17.5% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 33.4%, a beta of 0.17 and a maximum drawdown of 60.4%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 6 out of 10.
Top market events
- Second-quarter revenue reached USD 5.44 billion, up 7.50 percent year over year. Boston Scientific s
- Stryker Corporation NYSE:SYK traded at around $280 on October 6, 22.
- Revenue rose 7.50 percent to USD 5.44 billion in the second quarter. Boston Scientific stock costs E
Market outlook
Short term
< 1 yearNeutral
Model confidence1/101 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 59.36
- MACD momentum is positive
Medium term
1–3 yearsPositive
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- P/E of 17.9 versus sector average of 31.8
- Trading below the 200-day average of 59.36
Long term
> 3 yearsPositive
Model confidence6/106 out of 10
Key factors
- P/E of 17.9 versus sector average of 31.8
- Analyst targets imply +34.9% versus the current price
- Profit margin of 17.5% is healthy
Key metrics
Financial health
Revenue Growth7.50%
Profit Margin17.50%
P/E Ratio17.9
ROE15.34%
ROA6.19%
Debt/Equity50.15
P/B Ratio2.5
Op. Cash Flow$4.5B
Free Cash Flow$2.5B
Industry P/E31.8
Technical analysis
TrendBearish
RSI49.8
Support$41.39
Resistance$45.74
MA 20$43.38
MA 50$46.18
MA 200$59.36
MACDBullish
VolumeDecreasing
Fear & Greed Index90.39
Valuation
Fair Value$19.37
Target Price$59.24
Upside/Downside34.92%
GradeUndervalued
TypeBlend
Risk assessment
Beta0.17
Volatility33.44%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.